Kayne Anderson Rudnick Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.4M | Sell |
50,460
-1,447
| -3% | -$126K | 0.01% | 271 |
|
|
2025
Q1 | $3.54M | Sell |
51,907
-2,403
| -4% | -$164K | 0.01% | 292 |
|
|
2024
Q4 | $4.22M | Buy |
54,310
+22,458
| +71% | +$1.75M | 0.01% | 276 |
|
|
2024
Q3 | $2.14M | Sell |
31,852
-658
| -2% | -$44.1K | ﹤0.01% | 339 |
|
|
2024
Q2 | $3.69M | Sell |
32,510
-699
| -2% | -$79.3K | 0.01% | 297 |
|
|
2024
Q1 | $4.61M | Sell |
33,209
-1,146
| -3% | -$159K | 0.01% | 293 |
|
|
2023
Q4 | $4.26M | Buy |
34,355
+33,243
| +2,989% | +$4.13M | 0.01% | 298 |
|
|
2023
Q3 | $104K | Buy |
1,112
+319
| +40% | +$29.8K | ﹤0.01% | 461 |
|
|
2023
Q2 | $102K | Sell |
793
-154
| -16% | -$19.8K | ﹤0.01% | 460 |
|
|
2023
Q1 | $110K | Buy |
947
+2
| +0.2% | +$232 | ﹤0.01% | 449 |
|
|
2022
Q4 | $107K | Buy |
+945
| New | +$107K | ﹤0.01% | 460 |
|
|
2022
Q2 | – | Sell |
-28
| Closed | -$4K | – | 622 |
|
|
2022
Q1 | $4K | Buy |
28
+16
| +133% | +$2.29K | ﹤0.01% | 574 |
|
|
2021
Q4 | $2K | Buy |
+12
| New | +$2K | ﹤0.01% | 586 |
|